Cancer Mortality Declines but Rising Rates in Young Women Raise Concerns, ACS Reports
Cancer Mortality Declines, but Rising Rates in Young Women Raise Concerns
Cancer mortality in the United States has dropped by 34% over the past few decades, saving an estimated 4.5 million lives. However, a troubling trend has emerged: women under 50 are now 82% more likely to be diagnosed with cancer than men in the same age group, up from a 51% disparity in 2002. These findings come from a comprehensive analysis of national cancer data, highlighting both progress and persistent challenges in the fight against the disease.
In 2025, approximately 2 million new cancer cases are expected nationwide—about 5,600 diagnoses each day—alongside 618,120 cancer-related deaths. Breast cancer remains the most commonly diagnosed cancer among women, with 316,950 new cases and 42,170 deaths projected. Meanwhile, uterine cancer has become a growing concern, with survival rates declining over the past 40 years. Black women face a particularly stark disparity, with a 63% survival rate compared to 83% for White women. This gap is attributed to systemic inequities in healthcare access and funding. For example, in 2019, funding for cervical cancer research outpaced uterine cancer by nearly six to one, despite uterine cancer claiming three times as many lives in 2022.
Lung cancer, though declining in incidence, remains the deadliest form of the disease, with 124,730 deaths expected this year. The slower decline in women—1.4% annually compared to 3% in men—is linked to historical smoking patterns, as women began smoking later and have been slower to quit.
Cervical cancer rates tell a story of both progress and setbacks. Overall, cases have dropped by nearly 50% since the 1970s, thanks to widespread HPV vaccination, improved screening, and early treatment. However, rates among women aged 30 to 44 rose by 11% between 2013 and 2021. In contrast, women aged 20 to 24—the first generation to receive the HPV vaccine—saw a dramatic 69% decline in cases.
Liver cancer and melanoma rates have stabilized in men but continue to rise by about 2% annually in women over 50. For women under 50, melanoma rates have plateaued, but liver cancer cases are still increasing at a similar pace.
“The decline in cancer mortality due to reduced smoking, better treatments, and earlier detection is undoubtedly a win,” said Rebecca Siegel, senior scientific director of surveillance research and lead author of the report. “But the rising incidence among young and middle-aged women, who often serve as family caregivers, is deeply concerning. It’s a shift that echoes the early 1900s, when cancer was more common in women than men.”
To address these disparities, experts emphasize the need for increased investment in cancer prevention, treatment, and equitable care, particularly in high-risk communities. As the nation celebrates progress, the data underscores the importance of targeted efforts to ensure that no group is left behind in the fight against cancer.
The decline in cancer mortality over the past few decades is a testament to the remarkable progress made in early detection, treatment advancements, and public health initiatives, saving millions of lives. Though, the rising cancer rates among young women underscore the need for continued vigilance and targeted research to address this concerning trend. While the overall reduction in cancer deaths is a cause for optimism, the growing disparity in diagnoses between young women and men highlights the importance of understanding the underlying factors driving these changes. As we look ahead to the projected 2 million new cancer cases in 2025, it is clear that a multifaceted approach—combining prevention, early intervention, and equitable access to care—will be essential to sustain progress and address emerging challenges. By prioritizing research, raising awareness, and fostering collaboration across the medical and scientific communities, we can build on the gains achieved while ensuring that no demographic is left behind in the fight against cancer.
the fight against cancer has seen remarkable progress, with a 34% decline in mortality rates over the past few decades saving millions of lives. Though, the rising incidence of cancer among young women underscores the need for continued vigilance and targeted interventions. Disparities in survival rates, especially among Black women, highlight the urgent need to address systemic inequities in healthcare access and research funding. While advancements in prevention, such as HPV vaccination, have yielded notable successes, the resurgence of certain cancers in specific age groups demands a renewed focus on early detection, equitable care, and public health education. As we look ahead to the projected 2 million new cancer cases in 2025,it is indeed clear that a multifaceted approach—combining research,policy reform,and community engagement—will be essential to sustain progress and ensure that no demographic is left behind in the battle against this devastating disease. The data serves as both a testament to what we have achieved and a call to action for the challenges that remain.